Atypical Hemolytic Uremic Syndrome (aHUS)

• A Study Evaluating the Efficacy and Safety of Crovalimab in Pediatric Patients with Atypical Hemolytic Uremic Syndrome (aHUS) Recruiting
  2023-505638-82-00 5 2022-01-12
• A multicenter, single-arm, open-label study to evaluate efficacy and safety of switching from anti-C5 antibody treatment to iptacopan treatm … Recruiting
  2023-504550-35-00 5 2025-04-03
• Evaluate long-term safety, tolerability and efficacy of iptacopan in study participants with aHUS Recruiting
  2022-502965-34-00 5 2025-01-08
• A Study Evaluating the Efficacy and Safety of Crovalimab in Adult and Adolescent Patients with atypical Hemolytic Uremic Syndrome (aHUS) Recruitment ended
  2023-505089-27-00 5 2021-07-01

Showing 1–4 of 4 trials